Bon Secours Mercy Health is in late-stage talks to buy a majority stake in Surgery Partners, valuing the group at about $20 a share, the Financial Times reports, citing people familiar with the matter.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.